Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

InspireMD (NSPR) EBIAT (2016 - 2025)

InspireMD (NSPR) has 16 years of EBIAT data on record, last reported at -$12.7 million in Q3 2025.

  • For Q3 2025, EBIAT fell 61.06% year-over-year to -$12.7 million; the TTM value through Sep 2025 reached -$46.2 million, down 63.62%, while the annual FY2024 figure was -$32.0 million, 60.7% down from the prior year.
  • EBIAT reached -$12.7 million in Q3 2025 per NSPR's latest filing, up from -$13.2 million in the prior quarter.
  • Across five years, EBIAT topped out at -$3.2 million in Q1 2021 and bottomed at -$13.2 million in Q2 2025.
  • Average EBIAT over 5 years is -$6.4 million, with a median of -$5.1 million recorded in 2023.
  • Peak YoY movement for EBIAT: tumbled 82.31% in 2021, then grew 5.02% in 2023.
  • A 5-year view of EBIAT shows it stood at -$4.1 million in 2021, then decreased by 18.26% to -$4.8 million in 2022, then decreased by 11.56% to -$5.4 million in 2023, then plummeted by 69.73% to -$9.2 million in 2024, then crashed by 38.52% to -$12.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$12.7 million in Q3 2025, -$13.2 million in Q2 2025, and -$11.2 million in Q1 2025.